<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">mouse</item><item key="factors"><item><item key="GSM1442228"><item key="TREATMENT">no DOX</item></item></item><item><item key="GSM1442228"><item key="TREATMENT">no DOX</item></item></item><item><item key="GSM1442228"><item key="TREATMENT">no DOX</item></item></item><item><item key="GSM1442228"><item key="TREATMENT">no DOX</item></item></item><item><item key="GSM1442228"><item key="TREATMENT">no DOX</item></item></item><item><item key="GSM1442228"><item key="TREATMENT">no DOX</item></item></item><item><item key="GSM1442234"><item key="TREATMENT">DOX treated for 1dose of 15mg/kg</item></item></item><item><item key="GSM1442234"><item key="TREATMENT">DOX treated for 1dose of 15mg/kg</item></item></item><item><item key="GSM1442234"><item key="TREATMENT">DOX treated for 1dose of 15mg/kg</item></item></item><item><item key="GSM1442234"><item key="TREATMENT">DOX treated for 1dose of 15mg/kg</item></item></item><item><item key="GSM1442234"><item key="TREATMENT">DOX treated for 1dose of 15mg/kg</item></item></item><item><item key="GSM1442234"><item key="TREATMENT">DOX treated for 1dose of 15mg/kg</item></item></item></item><item key="id">7678</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">The clinical application of doxorubicin as a broad-spectrum anti-tumor antibiotic is limited greatly by its cardiotoxicity. Various...</item><item key="geo_gse_id">E-GEOD-59672</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">12</item><item key="tags"><item>cardiomyopathy</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-from-doxdoxorubicin-treated-wild-t</item><item key="geo_id_plat">E-GEOD-59672_A-AFFY-45</item><item key="name">Expression data from DOX(doxorubicin) -treated wild type or CHIP knockout C57BL/6J mice at day 5</item><item key="created">Nov.12, 2014</item><item key="summary">The clinical application of doxorubicin as a broad-spectrum anti-tumor antibiotic is limited greatly by its cardiotoxicity. Various mechanisms have been studied, but little is known about whether genes or pathways relevant with energy metabolism contributes to doxorubicin-induced cardiomyopathy or not. We used microarrays to detail the global expression profiling of acute cardiomyopathy induced by doxorubicin in wild type or CHIP knockout C57BL/6J mice and discovered distinct classes of changed genes during this process. The whole hearts were selected for RNA extraction and hybridization on Affymetrix microarrays at day 5 after a single intraperitoneal injection of doxorubicin at a dose of 15 mg/kg.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-59672</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-59672/samples/</item></data></biogps>
